Characterization of differentiated SH-SY5Y as neuronal screening model reveals increased oxidative vulnerability

Journal of Biomolecular Screening

Volumn 21, Issue 5, 2016, Pages 496-509

  Forster, J I ^a   Koglsberger S ^a   Trefois, C ^a   Boyd, O ^a   Baumuratov, A S ^a   Buck, L ^a   Balling, R ^a   Antony, P M A ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

differentiation; energetic stress; SH SY5Y; vulnerability

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEAT SHOCK PROTEIN; OXIDOPAMINE;

ARTICLE; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; ENERGY METABOLISM; GENE EXPRESSION; GENETIC SCREENING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES;

ADENOSINE TRIPHOSPHATE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEURONS; OXIDATIVE STRESS;

EID: 84970967863     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057115625190     Document Type: Article

References (31)

1. Krishna A., Biryukov M., Trefois C., et al. Systems Genomics Evaluation of the SH-SY5Y Neuroblastoma Cell Line as a Model for Parkinson's Disease. BMC Genomics 2014, 15, 1154.
2. Ross R. A., Spengler B. A., Biedler J. L., Coordinate Morphological and Biochemical Interconversion of Human Neuroblastoma Cells. J. Natl. Cancer Inst. 1983, 71, 741-747.
3. Påhlman S., Hoehner J. C., Nånberg E., et al. Differentiation and Survival Influences of Growth Factors in Human Neuroblastoma. Eur. J. Cancer 1995, 31A, 453-458.
4. Arcangeli A., Rosati B., Crociani O., et al. Modulation of HERG Current and Herg Gene Expression during Retinoic Acid Treatment of Human Neuroblastoma Cells: Potentiating Effects of BDNF. J. Neurobiol. 1999, 40, 214-225.
5. Matsumoto K., Wada R. K., Yamashiro J. M., et al. Expression of Brain-Derived Neurotrophic Factor and p145TrkB Affects Survival, Differentiation, and Invasiveness of Human Neuroblastoma Cells. Cancer Res. 1995, 55, 1798-1806.
6. Xun Z., Lee D.-Y., Lim J., et al. Retinoic Acid-Induced Differentiation Increases the Rate of Oxygen Consumption and Enhances the Spare Respiratory Capacity of Mitochondria in SH-SY5Y Cells. Mech. Ageing Dev. 2012, 133, 176-185.
7. Truckenmiller M. E., Vawter M. P., Cheadle C., et al. Gene Expression Profile in Early Stage of Retinoic Acid-Induced Differentiation of Human SH-SY5Y Neuroblastoma Cells. Restor. Neurol. Neurosci. 2001, 18, 67-80.
8. Sulzer D., Surmeier D. J., Neuronal Vulnerability, Pathogenesis, and Parkinson's Disease. Mov. Disord. 2013, 28, 41-50.
9. Otsu N., A Threshold Selection Method from Gray-Level Histograms. IEEE Trans. Syst. Man. Cybern. 1979, 9, 62-66.
10. Hellemans J., Mortier G., De Paepe A., et al. qBase Relative Quantification Framework and Software for Management and Automated Analysis of Real-Time Quantitative PCR Data. Genome Biol. 2007, 8, R19.
11. Akemann W., Mutoh H., Perron A., et al. Imaging Brain Electric Signals with Genetically Targeted Voltage-Sensitive Fluorescent Proteins. Nat. Methods 2010, 7, 643-649.
12. Mutoh H., Perron A., Akemann W., et al. Optogenetic Monitoring of Membrane Potentials. Exp. Physiol. 2011, 96, 13-18.
13. Perron A., Akemann W., Mutoh H., et al. Genetically Encoded Probes for Optical Imaging of Brain Electrical Activity. Prog. Brain Res. 2012, 196, 63-77.
14. Encinas M., Iglesias M., Llecha N., et al. Extracellular-Regulated Kinases and Phosphatidylinositol 3-Kinase Are Involved in Brain-Derived Neurotrophic Factor-Mediated Survival and Neuritogenesis of the Neuroblastoma Cell Line SH-SY5Y. J. Neurochem. 1999, 73, 1409-1421.
15. Encinas M., Iglesias M., Liu Y., et al. Sequential Treatment of SH-SY5Y Cells with Retinoic Acid and Brain-Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor-Dependent, Human Neuron-Like Cells. J. Neurochem. 2000, 75, 991-1003.
16. Presgraves S. P., Ahmed T., Borwege S., et al. Terminally Differentiated SH-SY5Y Cells Provide a Model System for Studying Neuroprotective Effects of Dopamine Agonists. Neurotox. Res. 2004, 5, 579-598.
17. Gillardon F., Leucine-Rich Repeat Kinase 2 Phosphorylates Brain Tubulin-Beta Isoforms and Modulates Microtubule Stability-A Point of Convergence in Parkinsonian Neurodegeneration? J. Neurochem. 2009, 110, 1514-1522.
18. Kaplan D. R., Matsumoto K., Lucarelli E., et al. Induction of TrkB by Retinoic Acid Mediates Biologic Responsiveness to BDNF and Differentiation of Human Neuroblastoma Cells. Eukaryotic Signal Transduction Group. Neuron 1993, 11, 321-331.
19. Scholz D., Pöltl D., Genewsky A., et al. Rapid, Complete and Large-Scale Generation of Post-Mitotic Neurons from the Human LUHMES Cell Line. J. Neurochem. 2011, 119, 957-971.
20. Korecka J. A., van Kesteren R. E., Blaas E., et al. Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional Profiling. PLoS One 2013, 8, e63862.
21. Sheng Z.-H., Cai Q., Mitochondrial Transport in Neurons: Impact on Synaptic Homeostasis and Neurodegeneration. Nat. Rev. Neurosci. 2012, 13, 77-93.
22. Roselli F., Caroni P., From Intrinsic Firing Properties to Selective Neuronal Vulnerability in Neurodegenerative Diseases. Neuron 2015, 85, 901-910.
23. Schneider L., Giordano S., Zelickson B. R., et al. Differentiation of SH-SY5Y Cells to a Neuronal Phenotype Changes Cellular Bioenergetics and the Response to Oxidative Stress. Free Radic. Biol. Med. 2011, 51, 2007-2017.
24. Chen S.-Y., Tsai S.-T., The Epidemiology of Parkinson's Disease. Tzu Chi Med. J. 2010, 22, 73-81.
25. Alegre-Abarrategui J., Christian H., Lufino M. M. P., et al. LRRK2 Regulates Autophagic Activity and Localizes to Specific Membrane Microdomains in a Novel Human Genomic Reporter Cellular Model. Hum. Mol. Genet. 2009, 18, 4022-4034.
26. Baulac S., Lu H., Strahle J., et al. Increased DJ-1 Expression under Oxidative Stress and in Alzheimer's Disease Brains. Mol. Neurodegener. 2009, 4, 12.
27. DuBois S. G., Kalika Y., Lukens J. N., et al. Metastatic Sites in Stage IV and IVS Neuroblastoma Correlate with Age, Tumor Biology, and Survival. J. Pediatr. Hematol. Oncol. 1999, 21, 181-189.
28. Cheung Y.-T., Lau W. K.-W., Yu M.-S., et al. Effects of All-Trans-Retinoic Acid on Human SH-SY5Y Neuroblastoma as In Vitro Model in Neurotoxicity Research. Neurotoxicology 2009, 30, 127-135.
29. Lopes F. M., Schröder R., da Frota M. L. C., et al. Comparison between Proliferative and Neuron-Like SH-SY5Y Cells as an In Vitro Model for Parkinson Disease Studies. Brain Res. 2010, 1337, 85-94.
30. Lopes F. M., Londero G. F., de Medeiros L. M., et al. Evaluation of the Neurotoxic/Neuroprotective Role of Organoselenides Using Differentiated Human Neuroblastoma SH-SY5Y Cell Line Challenged with 6-Hydroxydopamine. Neurotox. Res. 2012, 22, 138-149.
31. Virmani A., Gaetani F., Binienda Z., Effects of Metabolic Modifiers such as Carnitines, Coenzyme Q10, and PUFAs against Different Forms of Neurotoxic Insults: Metabolic Inhibitors, MPTP, and Methamphetamine. Ann. N. Y. Acad. Sci. 2005, 1053, 183-191.